Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
158,835,667
-
Number of holders
-
65
-
Total 13F shares, excl. options
-
12,980,577
-
Shares change
-
+1,326,322
-
Total reported value, excl. options
-
$121,887,208
-
Value change
-
+$12,525,355
-
Put/Call ratio
-
12%
-
Number of buys
-
39
-
Number of sells
-
21
-
Price
-
$9.39
Institutional Holders of TG THERAPEUTICS, INC. - COMMON STOCK (TGTX) as of Q2 2014
As of 30 Jun 2014 TG THERAPEUTICS, INC. - COMMON STOCK (TGTX) had 73 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 12,980,577 shares of stock of the company.
Largest 10 holders included BRIDGER MANAGEMENT, LLC, JPMORGAN CHASE & CO, BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, Visium Asset Management, LP, BlackRock Fund Advisors, COLUMBUS CIRCLE INVESTORS, JENNISON ASSOCIATES LLC, TFS CAPITAL LLC, and MILLENNIUM MANAGEMENT LLC.
This table shows 73 institutional shareholders of the security as of 30 Jun 2014.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.